MetLife Investment Management’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Hold |
44,656
| – | – | ﹤0.01% | 2084 |
|
|
2025
Q1 | $281K | Buy |
44,656
+5,871
| +15% | +$36.9K | ﹤0.01% | 2009 |
|
|
2024
Q4 | $160K | Buy |
38,785
+19,857
| +105% | +$81.8K | ﹤0.01% | 2414 |
|
|
2024
Q3 | $63.2K | Buy |
18,928
+47
| +0.2% | +$157 | ﹤0.01% | 2729 |
|
|
2024
Q2 | $56.3K | Sell |
18,881
-3,812
| -17% | -$11.4K | ﹤0.01% | 2739 |
|
|
2024
Q1 | $78.3K | Buy |
+22,693
| New | +$78.3K | ﹤0.01% | 2641 |
|